- Home
- NIU vs TRDA Comparison
NIU vs TRDA Comparison
Compare NIU & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIU
- TRDA
- Stock Information
- Founded
- NIU 2014
- TRDA 2016
- Country
- NIU China
- TRDA United States
- Employees
- NIU N/A
- TRDA N/A
- Industry
- NIU Auto Manufacturing
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- NIU Consumer Discretionary
- TRDA Health Care
- Exchange
- NIU Nasdaq
- TRDA Nasdaq
- Market Cap
- NIU 275.6M
- TRDA 233.5M
- IPO Year
- NIU 2018
- TRDA 2021
- Fundamental
- Price
- NIU $4.34
- TRDA $5.29
- Analyst Decision
- NIU
- TRDA Strong Buy
- Analyst Count
- NIU 0
- TRDA 3
- Target Price
- NIU N/A
- TRDA $25.67
- AVG Volume (30 Days)
- NIU 967.3K
- TRDA 228.9K
- Earning Date
- NIU 08-11-2025
- TRDA 11-04-2025
- Dividend Yield
- NIU N/A
- TRDA N/A
- EPS Growth
- NIU N/A
- TRDA N/A
- EPS
- NIU N/A
- TRDA N/A
- Revenue
- NIU $527,760,629.00
- TRDA $79,476,000.00
- Revenue This Year
- NIU $41.32
- TRDA N/A
- Revenue Next Year
- NIU $24.38
- TRDA N/A
- P/E Ratio
- NIU N/A
- TRDA N/A
- Revenue Growth
- NIU 32.62
- TRDA N/A
- 52 Week Low
- NIU $1.66
- TRDA $4.93
- 52 Week High
- NIU $5.37
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- NIU 51.37
- TRDA 41.34
- Support Level
- NIU $4.20
- TRDA $5.17
- Resistance Level
- NIU $4.96
- TRDA $5.66
- Average True Range (ATR)
- NIU 0.24
- TRDA 0.32
- MACD
- NIU -0.07
- TRDA 0.01
- Stochastic Oscillator
- NIU 15.91
- TRDA 10.91
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.